AGEN
Agenus Inc.
Price
chg
quotes and stock data delayed 15 minutes
Cash
$79.2M
Burn Rate (Qtr)
$47.5M
Mkt Cap
mkt cap api
52 wk hi
52 wk low
low api
high api
*cash/burn updated:
Q3 '20
Company Profile
The company’s I-O portfolio is comprised of checkpoint antibodies, cell therapies, vaccines, and adjuvants, representing a combination of synergistic agents to deliver curative patient outcomes
Drug Pipeline
Click on drug name or indication to see upcoming trial info, prior data, and more general information
Drug | Disease (links)
Stage (next event)
Catalyst Date
Recent Posts
See what the community is saying - click to see full post